INVARIANT LLC for CIGNA CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act, the high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 5963, regarding relief from the Health Insurance Tax. Issues related to the implementation of international tax provisions under P.L. 115-97, the Tax Cuts and Jobs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
| KATHRYN WISE | — |
Health Issues HCR
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms, non-discrimination provisions, the high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, regarding a one-year delay of the Cadillac Tax, H.R. 4620, regarding relief from the Health Insurance Tax, Substance use disorders, and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically H.R. 3545, H.R. 5795, and H.R.6082, the Overdose Prevention and Patient Safety Act (OPPS Act), and H.R. 6, the SUPPORT for Patients and Communities Act. Issues related to proposed changes to the definition of Employer Under Section 3(5) of ERISA for Association Health Plans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
| KATHRYN WISE | — |
Medicare/Medicaid MMM
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program; Issues related to the opioid epidemic and introduced H.R. 6, SUPPORT for Patients and Communities Act; Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
| KATHRYN WISE | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to anti-trust and the proposed Cigna-Express Scripts transaction; Issues related to proposed changes to the definition of Employer Under Section 3(5) of ERISA for Association Health Plans.17. House(s) of Congress and Federal Agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNE PALISI | — |
| HEATHER PODESTA | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.